【巨子生物盘中涨近 3%】截至发稿，巨子生物股价上涨 2.34%，现报 78.90 港元，成交额 2.01 亿港元。中信指出，重组胶原蛋白行业在技术、工艺上持续进步，继 I 型、III 型后在 XVII 型、IV 型以及多型别组合方面再现突破。各龙头公司在结构解析、发酵制备、产品化、商业化方面的闭环能力更为成熟。格局方面，各公司均综合布局“妆&二类械&消费/严肃医疗三类械”，同时又在各自擅长的品类...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.